Navigation Links
Sigma-Aldrich Names Helge Bastian New VP of Global Marketing for Research Biotech
Date:2/19/2008

ST. LOUIS, Feb. 19 /PRNewswire-FirstCall/ -- Sigma-Aldrich(R) (Nasdaq: SIAL) is pleased to announce that Helge Bastian, Ph.D, has joined Sigma-Aldrich as Vice President of Global Marketing for the Research Biotech business unit. Dr. Bastian will be responsible for our strategic and commercial marketing efforts to drive top line growth through the identification, development and launch of innovative products into the life science market. Dr. Bastian has over 15 years of international leadership experience in the molecular biology and diagnostics, biotechnology, drug development and pharmaceutical manufacturing industry.

He was previously executive vice president of the Life Science Services business unit at SGS, a leading inspection, verification and certification company, and member of the senior executive management team in Geneva, Switzerland. Helge held various management positions at QIAGEN for more than 11 years, including Vice President of Molecular Diagnostics, Vice President of Global Strategic Marketing and Vice President of PreAnalytiX, and member of QIAGEN's executive steering committee and PreAnalytiXs management committee.

Helge studied biology at the Universities in Kiel, Gottingen, and Munich, Germany, and holds a diploma in biology (focus area of biochemistry) and a Ph.D. in molecular biology conducted at the Max-Planck Institute for Biophysical Chemistry from the University of Gottingen, Germany. He is an alumnus from the Max-Planck Network and the Columbia Business School.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning website at http://www.sigma-aldrich.com.

Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Company's expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Company's operations and conditions in the markets the Company serves. The Company does not undertake any obligation to update these forward-looking statements.


'/>"/>
SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Announces New Prestige Antibodies(TM) Line for Proteomics and Cell Biology Researchers
2. Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark.
3. Sigma-Aldrich Corporations 4th Quarter 2007 Earnings Conference Call
4. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
5. Sigma-Aldrich Announces Launch of a New Antibodies Catalog
6. Saint Louis University Honors Sigma-Aldrich Corp. for $1 Million Donation
7. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
8. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
11. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... While things have been quiet for EcoloCap over the past ... new outlook for the future. As a continued effort to bring innovative technology ... of Mr. Siegel as CEO. With the new adjustments in management, EcoloCap has introduced ...
(Date:4/27/2017)... Md. and RESEARCH TRIANGLE PARK, ... Therapeutics Corporation (NASDAQ: UTHR ) today announced ... up to $250 million of the company,s common stock. ... open through December 31, 2017. Purchases may be made ... privately negotiated transactions from time to time as determined ...
(Date:4/27/2017)... ... 27, 2017 , ... Proscia Inc., a ... technology has the potential to eliminate subjectivity in the detection and classification of ... part of the 2017 ISBI CAMELYON Digital Pathology Challenge, organized by ...
(Date:4/27/2017)... ... April 27, 2017 , ... This month Quorum Review ... that simplifies research studies, accelerates study startup, and improves participant engagement. Developed by ... the first and only IRB-integrated eConsent solution . , “Our mission at ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
Breaking Biology News(10 mins):